Table of contents
Volume 92, Issue 9
Published online 3 May 2005 (1591-1816)
Minireview |
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Epidemiology |
Letters to the Editor
Editorial
Human papillomavirus testing in cervical cancer screening FREE
S Franceschi and C Mahé
Br J Cancer 92: 1591-1592; doi:10.1038/sj.bjc.6602580
Minireview
HMG CoA reductase inhibitors (statins) to treat Epstein–Barr virus-driven lymphoma FREE
J I Cohen
Br J Cancer 92: 1593-1598; advance online publication, April 26, 2005; doi:10.1038/sj.bjc.6602561
Clinical Studies
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations FREE
M O Leach, K M Brindle, J L Evelhoch, J R Griffiths, M R Horsman, A Jackson, G C Jayson, I R Judson, M V Knopp, R J Maxwell, D McIntyre, A R Padhani, P Price, R Rathbone, G J Rustin, P S Tofts, G M Tozer, W Vennart, J C Waterton, S R Williams and P Workman
Br J Cancer 92: 1599-1610; doi:10.1038/sj.bjc.6602550
Effects of cisplatin on olfactory function in cancer patients FREE
A Yakirevitch, Y P Talmi, Y Baram, R Weitzen and M R Pfeffer
Br J Cancer 92: 1611-1613; advance online publication, April 12, 2005; doi:10.1038/sj.bjc.6602544
Myocardial infarction risk and tamoxifen therapy for breast cancer FREE
A M Geiger, W Chen and L Bernstein
Br J Cancer 92: 1614-1620; advance online publication, April 19, 2005; doi:10.1038/sj.bjc.6602562
Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer FREE
R V Iaffaioli, R Formato, A Tortoriello, S Del Prete, M Caraglia, G Pappagallo, A Pisano, F Fanelli, G Ianniello, S Cigolari, C Pizza, O Marano, G Pezzella, T Pedicini, A Febbraro, P Incoronato, L Manzione, E Ferrari, N Marzano, S Quattrin, S Pisconti, G Nasti, G Giotta and G Colucci other Goim authors
Br J Cancer 92: 1621-1625; advance online publication, April 26, 2005; doi:10.1038/sj.bjc.6602579
Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancer FREE
I Willits, L Price, A Parry, M J Tilby, D Ford, S Cholerton, A D J Pearson and A V Boddy
Br J Cancer 92: 1626-1635; advance online publication, April 12, 2005; doi:10.1038/sj.bjc.6602554
Phase I and pharmacokinetic study of the novel chemoprotector BNP7787 in combination with cisplatin and attempt to eliminate the hydration schedule FREE
E Boven, M Westerman, C J van Groeningen, M Verschraagen, R Ruijter, I Zegers, W J F van der Vijgh and G Giaccone
Br J Cancer 92: 1636-1643; advance online publication, April 19, 2005; doi:10.1038/sj.bjc.6602553
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients FREE
F De Vita, M Orditura, E Matano, R Bianco, C Carlomagno, S Infusino, V Damiano, E Simeone, M R Diadema, E Lieto, P Castellano, S Pepe, S De Placido, G Galizia, N Di Martino, F Ciardiello, G Catalano and A R Bianco
Br J Cancer 92: 1644-1649; advance online publication, April 26, 2005; doi:10.1038/sj.bjc.6602573
Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer FREE
S Rao, D Cunningham, R E Hawkins, M E Hill, D Smith, F Daniel, P J Ross, J Oates and A R Norman
Br J Cancer 92: 1650-1654; advance online publication, April 26, 2005; doi:10.1038/sj.bjc.6602576
A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer FREE
W Schippinger, M Jagoditsch, C Sorré, M Gnant, G Steger, H Hausmaninger, B Mlineritsch, R Schaberl-Moser, H J Mischinger, F Hofbauer, P Holzberger, M Mittlböck and R Jakesz for the Austrian Breast and Colorectal Cancer Study Group
Br J Cancer 92: 1655-1662; advance online publication, April 26, 2005; doi:10.1038/sj.bjc.6602555
A modified Inflammatory Bowel Disease questionnaire and the Vaizey Incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy FREE
F A Olopade, A Norman, P Blake, D P Dearnaley, K J Harrington, V Khoo, D Tait, C Hackett and H J N Andreyev
Br J Cancer 92: 1663-1670; advance online publication, April 26, 2005; doi:10.1038/sj.bjc.6602552
Communication in cancer genetic counselling: does it reflect counselees' previsit needs and preferences? FREE
A H Pieterse, A M van Dulmen, M G E M Ausems, F A Beemer and J M Bensing
Br J Cancer 92: 1671-1678; advance online publication, April 19, 2005; doi:10.1038/sj.bjc.6602570
Fast recruiting clinical trials – a Utopian dream or logistical nightmare? FREE
L Johnson, P Ellis and J M Bliss
Br J Cancer 92: 1679-1683; advance online publication, April 19, 2005; doi:10.1038/sj.bjc.6602574
Translational Therapeutics
Preclinical relevance of dosing time for the therapeutic index of gemcitabine–cisplatin FREE
X M Li, K Tanaka, J Sun, E Filipski, L Kayitalire, C Focan and F Lévi
Br J Cancer 92: 1684-1689; advance online publication, April 19, 2005; doi:10.1038/sj.bjc.6602564
Selective inhibition of TNF-
-induced activation of mitogen-activated protein kinases and metastatic activities by gefitinib FREE
Y Ueno, H Sakurai, M Matsuo, M K Choo, K Koizumi and I Saiki
Br J Cancer 92: 1690-1695; advance online publication, April 19, 2005; doi:10.1038/sj.bjc.6602548
Cooperative stimulation of vascular endothelial growth factor expression by hypoxia and reactive oxygen species: the effect of targeting vascular endothelial growth factor and oxidative stress in an orthotopic xenograft model of bladder carcinoma FREE
N S Brown, E H Streeter, A Jones, A L Harris and R Bicknell
Br J Cancer 92: 1696-1701; advance online publication, April 19, 2005; doi:10.1038/sj.bjc.6602522
A potent nonporphyrin class of photodynamic therapeutic agent: cellular localisation, cytotoxic potential and influence of hypoxia FREE
W M Gallagher, L T Allen, C O'Shea, T Kenna, M Hall, A Gorman, J Killoran and D F O'Shea
Br J Cancer 92: 1702-1710; advance online publication, April 19, 2005; doi:10.1038/sj.bjc.6602527
Molecular Diagnostics
Reduction of PTEN protein and loss of epidermal growth factor receptor gene mutation in lung cancer with natural resistance to gefitinib (IRESSA) FREE
Y Kokubo, A Gemma, R Noro, M Seike, K Kataoka, K Matsuda, T Okano, Y Minegishi, A Yoshimura, M Shibuya and S Kudoh
Br J Cancer 92: 1711-1719; doi:10.1038/sj.bjc.6602559
Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ FREE
P Wülfing, C Kersting, H Buerger, B Mattsson, R Mesters, C Gustmann, B Hinrichs, J Tio, W Böcker and L Kiesel
Br J Cancer 92: 1720-1728; advance online publication, April 19, 2005; doi:10.1038/sj.bjc.6602567
Expression of lysophosphatidic acid acyltransferase beta (LPAAT-
) in ovarian carcinoma: correlation with tumour grading and prognosis FREE
S Niesporek, C Denkert, W Weichert, M Köbel, A Noske, J Sehouli, J W Singer, M Dietel and S Hauptmann
Br J Cancer 92: 1729-1736; advance online publication, April 19, 2005; doi:10.1038/sj.bjc.6602528
Clinical significance of heparin-binding epidermal growth factor-like growth factor in peritoneal fluid of ovarian cancer FREE
H Yagi, S Miyamoto, Y Tanaka, K Sonoda, H Kobayashi, T Kishikawa, R Iwamoto, E Mekada and H Nakano
Br J Cancer 92: 1737-1745; advance online publication, April 12, 2005; doi:10.1038/sj.bjc.6602536
Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases FREE
A Buckowitz, H-P Knaebel, A Benner, H Bläker, J Gebert, P Kienle, M von Knebel Doeberitz and M Kloor
Br J Cancer 92: 1746-1753; advance online publication, April 26, 2005; doi:10.1038/sj.bjc.6602534
Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma FREE
T Sudo, T Utsunomiya, K Mimori, H Nagahara, K Ogawa, H Inoue, S Wakiyama, H Fujita, K Shirouzu and M Mori
Br J Cancer 92: 1754-1758; advance online publication, April 26, 2005; doi:10.1038/sj.bjc.6602531
Fluorescence in situ hybridisation analysis of chromosomal aberrations in gastric tissue: the potential involvement of Helicobacter pylori FREE
L Williams, G J S Jenkins, S H Doak, P Fowler, E M Parry, T H Brown, A P Griffiths, J G Williams and J M Parry
Br J Cancer 92: 1759-1766; advance online publication, April 12, 2005; doi:10.1038/sj.bjc.6602533
Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer FREE
I Songun, S V Litvinov, C J H van de Velde, S T Pals, J Hermans and J H J M van Krieken
Br J Cancer 92: 1767-1772; doi:10.1038/sj.bjc.6602519
Garlic arrests MDA-MB-435 cancer cells in mitosis, phosphorylates the proapoptotic BH3-only protein BimEL and induces apoptosis FREE
T Lund, T Stokke, Ø E Olsen and Ø Fodstad
Br J Cancer 92: 1773-1781; advance online publication, April 12, 2005; doi:10.1038/sj.bjc.6602537
Epidemiology
No association between fruit or vegetable consumption and the risk of colorectal cancer in Japan FREE
Y Tsubono, T Otani, M Kobayashi, S Yamamoto, T Sobue and S Tsugane for the JPHC Study Group
Br J Cancer 92: 1782-1784; advance online publication, April 26, 2005; doi:10.1038/sj.bjc.6602566
Serum cholesterol and testicular cancer incidence in 45 000 men followed for 25 years FREE
A-B Wiréhn, S Törnberg and J Carstensen
Br J Cancer 92: 1785-1786; advance online publication, April 12, 2005; doi:10.1038/sj.bjc.6602539
Maternal hormone levels among populations at high and low risk of testicular germ cell cancer FREE
Y Zhang, B I Graubard, M A Klebanoff, C Ronckers, F Z Stanczyk, M P Longnecker and K A McGlynn
Br J Cancer 92: 1787-1793; advance online publication, April 19, 2005; doi:10.1038/sj.bjc.6602545
Human papillomavirus infection in women who develop high-grade cervical intraepithelial neoplasia or cervical cancer: a case–control study in the UK FREE
M J Grainge, R Seth, C Coupland, L Guo, T Rittman, P Vryenhoef, J Johnson, D Jenkins and K R Neal
Br J Cancer 92: 1794-1799; advance online publication, April 12, 2005; doi:10.1038/sj.bjc.6602538
Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening FREE
N W J Bulkmans, L Rozendaal, F J Voorhorst, P J F Snijders and C J L M Meijer
Br J Cancer 92: 1800-1802; advance online publication, April 12, 2005; doi:10.1038/sj.bjc.6602541
Whole grain consumption and risk of colorectal cancer: a population-based cohort of 60 000 women FREE
S C Larsson, E Giovannucci, L Bergkvist and A Wolk
Br J Cancer 92: 1803-1807; advance online publication, April 12, 2005; doi:10.1038/sj.bjc.6602543
Cancer survival in Kampala, Uganda FREE
A Gondos, H Brenner, H Wabinga and D M Parkin
Br J Cancer 92: 1808-1812; advance online publication, April 12, 2005; doi:10.1038/sj.bjc.6602540
Letters to the Editor
P53 abnormalities and outcomes in colorectal cancer: a systematic review FREE
F M Smith, R B Stephens, M J Kennedy and J V Reynolds
Br J Cancer 92: 1813; advance online publication, April 26, 2005; doi:10.1038/sj.bjc.6602589
An inverse association between tumour size and overdiagnosis may explain the results by Bucchi et al FREE
P-H Zahl
Br J Cancer 92: 1814; advance online publication, April 26, 2005; doi:10.1038/sj.bjc.6602581
Reply: An inverse association between tumour size and overdiagnosis may explain the results by Bucchi et al FREE
L Bucchi, A Barchielli, A Ravaioli, M Federico, V De Lisi, S Ferretti, E Paci, M Vettorazzi, S Patriarca, A Frigerio and E Buiatti and the SCREENREG Working Group
Br J Cancer 92: 1815-1816; advance online publication, April 26, 2005; doi:10.1038/sj.bjc.6602583
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
